| Market Cap | ₹171Cr | 
| ROE | 2.51% | 
| P/E Ratio(TTM) | 0.00 | 
| EPS(TTM) | 0.23 | 
| P/B Ratio | 19.21 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 40.92 | 
| Book Value | 7.84 | 
| Debt to Equity | 0.00 | 
| Face Value | 10 | 
| Parent Organisation | Mahavir Advanced Remedies Limited | 
| Managing Director | Mr. BVS Rao | 
| Founded | 1992 | 
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |